戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 se endocrine abnormalities in HIV, including growth hormone-releasing hormone.
2 cagon, glucagon-like peptides, secretin, and growth hormone-releasing hormone.
3                                              Growth hormone-releasing hormone agonists (GHRH-As) have
4                                              Growth hormone-releasing hormone, an agonist that stimul
5                               Tesamorelin, a growth hormone-releasing hormone analog, specifically ta
6       We leveraged a randomized trial of the growth hormone-releasing hormone analogue tesamorelin to
7                               Tesamorelin, a growth hormone-releasing hormone analogue, decreases vis
8  of somatostatin and decreased expression of growth hormone-releasing hormone and growth hormone-rece
9                             One encoded both growth hormone-releasing hormone and PACAP, whereas the
10 necroptosis, mitotane-induced cell death and growth hormone-releasing hormone antagonist-induced necr
11 oph D2 DA receptors and depress hypothalamic growth hormone-releasing hormone content.
12  receptors that stimulated adenylyl cyclase, growth hormone-releasing hormone, corticotropin-releasin
13 on of a new serum protease-resistant porcine growth hormone-releasing hormone, directed by an injecta
14 ic IGF-1 production resulted from diminished growth hormone-releasing hormone expression in the hypot
15 cinoma (RCC), we investigated the effects of growth hormone-releasing hormone (GH-RH) antagonist MZ-4
16      Recent studies show that antagonists of growth hormone-releasing hormone (GH-RH) inhibit prolife
17                               Antagonists of growth hormone-releasing hormone (GH-RH) inhibit the gro
18 ental cancers, treatment with antagonists of growth hormone-releasing hormone (GH-RH) produces a redu
19 c and antidepressant-like effects of a novel growth hormone releasing hormone (GHRH) antagonist of MI
20 ch regulator protein, the other an inducible growth hormone releasing hormone (GHRH) gene, into the t
21                                              Growth hormone releasing hormone (GHRH) is the integral
22 elanocortin (POMC), neuropeptide Y (NPY) and growth hormone releasing hormone (GHRH) neurons, regulat
23 he median eminence was partially depleted of growth hormone releasing hormone (GHRH) within 48 hours
24 ac stem cells (CSCs) express the receptor of growth hormone releasing hormone (GHRH), activation of w
25 c alkaline phosphatase (SEAP) or therapeutic growth hormone releasing hormone (GHRH).
26                        Pretreatment with the growth hormone-releasing hormone (GHRH) agonist, JI-36,
27                                      Because growth hormone-releasing hormone (GHRH) and GHRH recepto
28 ) deficiency with inadequate compensation by Growth hormone-releasing hormone (GHRH) and Growth hormo
29                                              Growth hormone-releasing hormone (GHRH) and its ability
30                                         Both growth hormone-releasing hormone (GHRH) and its potent a
31                    The roles of hypothalamic growth hormone-releasing hormone (GHRH) and of somatosta
32                   The stimulatory effects of growth hormone-releasing hormone (GHRH) and the antiprol
33  therapeutic effects of agonistic analogs of growth hormone-releasing hormone (GHRH) and their mechan
34                                              Growth hormone-releasing hormone (GHRH) antagonist MIA-6
35             Preclinical studies suggest that growth hormone-releasing hormone (GHRH) antagonists effe
36          The strong inhibitory activities of growth hormone-releasing hormone (GHRH) antagonists have
37               We investigated the effects of growth hormone-releasing hormone (GHRH) antagonists, JV-
38               Finally, we also detected that growth hormone-releasing hormone (GHRH) antagonists, suc
39                               Antagonists of growth hormone-releasing hormone (GHRH) are being develo
40                           Peptide analogs of growth hormone-releasing hormone (GHRH) can potentially
41                                 Hypothalamic growth hormone-releasing hormone (GHRH) controls the rel
42           Here we tested the hypothesis that growth hormone-releasing hormone (GHRH) directly activat
43 eurons, and two growth-stimulatory peptides, growth hormone-releasing hormone (GHRH) for GHRH-neurons
44            Ectopic expression of a truncated growth hormone-releasing hormone (GHRH) from muscle tiss
45  The gsh-1 gene is shown to be essential for growth hormone-releasing hormone (GHRH) gene expression
46                                              Growth hormone-releasing hormone (GHRH) has been previou
47       Splice variants (SVs) of receptors for growth hormone-releasing hormone (GHRH) have been found
48                                  Agonists of growth hormone-releasing hormone (GHRH) have been previo
49 examine the impact of targeted disruption of growth hormone-releasing hormone (GHRH) in mice on longe
50 us tumors is inhibited by the antagonists of growth hormone-releasing hormone (GHRH) in vitro and in
51 sed the following GH measures: (1) GH before growth hormone-releasing hormone (GHRH) infusion, every
52                  Antagonists of hypothalamic growth hormone-releasing hormone (GHRH) inhibit growth o
53                               Antagonists of growth hormone-releasing hormone (GHRH) inhibit the grow
54                               Antagonists of growth hormone-releasing hormone (GHRH) inhibit the grow
55                               Antagonists of growth hormone-releasing hormone (GHRH) inhibit the prol
56                                              Growth hormone-releasing hormone (GHRH) is a hypothalami
57               Previous reports indicate that growth hormone-releasing hormone (GHRH) is involved in s
58 ia induced by transgenic expression of human growth hormone-releasing hormone (GHRH) is significantly
59 ntiproliferative effects of an antagonist of growth hormone-releasing hormone (GHRH) JV-1-38 were eva
60 We investigated the effect of antagonists of growth hormone-releasing hormone (GHRH) MZ-J-7-138 and J
61                                 Hypothalamic growth hormone-releasing hormone (GHRH) neurons orchestr
62                                              Growth hormone-releasing hormone (GHRH) promotes non-rap
63                       It has been shown that growth hormone-releasing hormone (GHRH) reduces cardiomy
64                             The hypothalamic growth hormone-releasing hormone (GHRH) regulates the re
65                                 Hypothalamic growth hormone-releasing hormone (GHRH) stimulates growt
66                      Antagonistic analogs of growth hormone-releasing hormone (GHRH) suppress growth
67                               Antagonists of growth hormone-releasing hormone (GHRH) synthesized prev
68                               Antagonists of growth hormone-releasing hormone (GHRH) were shown to in
69                                              Growth hormone-releasing hormone (GHRH), a hypothalamic
70  variant SV1 of the hypothalamic polypeptide growth hormone-releasing hormone (GHRH), as well as for
71 y hormone precursors, including hypothalamic growth hormone-releasing hormone (GHRH), pituitary proop
72 ith corticotropin-releasing factor (CRF) and growth hormone-releasing hormone (GHRH), suggesting nove
73        In view of the multiple activities of growth hormone-releasing hormone (GHRH), we hypothesized
74 /h) potently suppressed both spontaneous and growth hormone-releasing hormone (GHRH)-induced GH secre
75 eport that Mll4 regulates the development of growth hormone-releasing hormone (GHRH)-producing neuron
76 re transplantation using a potent agonist of growth-hormone-releasing hormone (GHRH) to promote islet
77 ine system: corticotropin-releasing hormone, growth hormone-releasing hormone, gonadotropin-releasing
78 s LHn from serotype D with a fragment of the growth hormone releasing hormone, has previously reveale
79                    Some antagonists of human growth hormone-releasing hormone (hGH-RH) synthesized pr
80                         Antagonists of human growth hormone-releasing hormone (hGHRH) with increased
81 cludes corticotropin-releasing factor (CRF), growth hormone-releasing hormone, incretin, and pituitar
82 esis, metallothionein promoter-driven, human growth hormone-releasing hormone (MT-hGHRH) transgenic m
83 onship scans of the active fragment of human growth hormone-releasing hormone, [Nle27]-hGHRH(1-29)-NH
84 lation when stimulated with either secretin, growth hormone-releasing hormone, or calcitonin.
85 sion in the hypothalamus, leading to reduced growth hormone releasing hormone, pituitary growth hormo
86  in fact, they are runted due to a defect in growth-hormone releasing hormone processing, leading to
87                                   Previously growth hormone releasing hormone receptor (GHRH-R) defic
88        The beneficial effects of agonists of growth hormone-releasing hormone receptor (GHRH-R) in he
89                                              Growth hormone-releasing hormone receptor (GHRH-R) is ex
90 trated the beneficial effects of agonists of growth hormone-releasing hormone receptor (GHRH-R), such
91 RK2) and ADAM 10 were overexpressed, whereas growth hormone-releasing hormone receptor (GHRHR) and Ho
92 ine methyl ester (L-NAME) and stimulation of growth hormone-releasing hormone receptor (GHRHR) with G
93   Various attempts to detect human pituitary growth hormone-releasing hormone receptor (pGHRH-R) in n
94       In these patients, mutations disrupted growth hormone-releasing hormone receptor signaling, but
95                               Tesamorelin, a growth hormone-releasing hormone, reduces AO and increas